TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Benjamin Loos(University of Zurich), Lukas Sommer(University of Zurich), Reinhard Dummer(University Hospital of Zurich), Phil F. Cheng(University Hospital of Zurich), Stefanie Rufli(University of Zurich), Adrián Salas-Bastos(University of Zurich), C. Wyss(University of Zurich), Claudio Cantù(Linköping University), Julien Debbache(University of Zurich), Salome Stierli(University of Zurich), Steve Pascolo(University of Zurich), Mitchell P. Levesque(Duke University), Anna Nordin(Linköping University), W. Wei‐Lynn Wong(Johns Hopkins University)
Cited by 11
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
|Nature Communications|2015|332